𝔖 Bobbio Scriptorium

✦ LIBER ✦

165 Effect of fialuridine (FIAU) on the in vitro replication of mitochondrial DNA in human T cells and in human hepatoblastoma cells: J. M. Colacino∗, S. K. Malcolm, and S. R. Jaskunas. Lilly Research Laboratories, Indianapolis, Indiana, USA

Book ID: 118393610
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 86 KB
Volume: 23
Category: Article
ISSN: 0166-3542
DOI: 10.1016/0166-3542(94)90288-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

220 The in vitro anti-hepatitis B virus

220 The in vitro anti-hepatitis B virus activity of FIAU is selective, reversible, and determined, at least in part, by the host cell: J. M. Colacino, K. A. Staschke, T. E. Mabry, and C. D. Jones. Lilly Research Laboratories, Indianapolis, Indiana, USA

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 71 KB

221 In vitro anti-hepatitis B virus and

221 In vitro anti-hepatitis B virus and anti-human cytomegalovirus activities of selected 2′, 2′-difluoro purine and pyrimidine nucleoside analogs: J. M. Colacino, C. S. Grossman, K. A. Staschke, A. J. Schilke, J. S. Kroin and L. W. Hertel. Lilly Research Laboratories, Indianapolis, Indiana, USA

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Use of a filter binding sample preparati

Use of a filter binding sample preparation method for the PCR detection of hepatitis B virus (HBV) in cell culture or in human sera and for the demonstration of the anti-HBV activity of two halogenated pyrimidine nucleoside analogs : 1K. A. Staschke, 1J. M. Colacino, and 2C.-H. Lee. 1Lilly Research Laboratories and 2Indiana University School of Medicine, Indianapolis, Indiana, USA

📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 53 KB

44 Combination of LY300082 with AZT and

44 Combination of LY300082 with AZT and DDI give synergistic effects on HIV replication in cells and on HIV reverse transcriptase: H. Zhang1, L. Vrang1, K. Backro2, T. Unge2, P. Engelhardt1, M. Hogberg1, J. Kangasmetsa1, P. Lind1, R. Noreen1, C. Sahlberg1, X.-X. Zhou1, N. G. Johansson1, J. M. Morin, Jr.3, R. J. Ternansky3, F. W. Bell3, C. L. Jordan3, M. D. Kinnick3, J. A. Palkowitz3, C. A. Parrish3, P. Pranc3, R. T. Vasileff3, S. J. West3, and B. Oberg1,2. 1Medivir AB, Huddinge, Sweden; Department of Molecular Biology, BMC, Uppsala, Sweden; 3Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 50 KB